C hronic obstructive pulmonary disease (COPD) is frequently punctuated by acute exacerbations (AECOPD). 1 Currently, more than 80% of these events are recommended to be managed within the community since it can shorten the length of hospital stays and/or avoid hospital admittance. 2 Pulmonary rehabilitation is a well-established, evidenced-based intervention, possible to be applied within the community (ie, in nonspecialized community health services, in community centers, or at the patient's home) [3] [4] [5] [6] and with potential to prevent and decrease the harmful effects of acute exacerbations. 7 Costs associated with AECOPD in the United States are estimated in $7100 per patient/per exacerbation 8 and recent economic studies have shown that, compared with usual care, community-based pulmonary rehabilitation provides cost savings of $1098 per patient. 9 Nevertheless, conflicting results regarding the clinical effects of pulmonary rehabilitation in AECOPD have been reported 10, 11 and less than 10% of patients discharged from AECOPD are being referred for pulmonary rehabilitation 12 thus, its implementation is not a common practice. This inconsistency among studies may occur due to the wide variety of outcomes and outcome measures used and/or due to the lack of appropriate measurement properties (ie, reliability, validity and responsiveness) of the outcome measures used in exacerbation periods. It is known that the measurement properties of any outcome measure are population specific 13 and that patients at distinct phases of their chronic disease (stable/exacerbation) differ in the physiologic and ventilatory mechanisms of their lungs. 14 Therefore, it can be hypothesized that instrument measurement properties will also vary in stable and exacerbation periods.
Nevertheless, studies involving pulmonary rehabilitation in patients with AECOPD have been choosing their outcome measures based on the measurement properties established for stable patients with COPD, 15, 16 which may hinder the development of pulmonary rehabilitation guidelines and lead instead to publication of recommendations which lack rigorous underpinning evidence in exacerbation periods.
Additionally, attending to patient's level of fragility during exacerbations, the specificities of implementing a pulmonary rehabilitation program in a nonspecialized center and some practical issues, such as the need for specific equipment and sufficient space and time required to complete testing, especially when more than 1 test at baseline is required, may also influence the selection of the outcome measure. 17 Thus, the 2 aims of this systematic review were to identify patient-reported outcome measures (PROMs) and clinical (non-patient-reported) outcome measures that are used to assess the effects of pulmonary rehabilitation interventions in patients with AECOPD and that can be easily applied in the community (ie, not expensive, not invasive, and quickly implemented) and to synthesize/evaluate their measurement properties.
Methods
This systematic review (PROSPERO registration no. CRD42015023736) was conducted in 2 phases. Phase 1 identified outcome measures used to assess outcomes of pulmonary rehabilitation interventions in patients with AECOPD and that can be easily applied in community-based practice. Phase 2 aimed to assess the measurement properties of the identified outcome measures.
Phase 1: Measures Used in Pulmonary Rehabilitation
Data sources and searches. The effects of pulmonary rehabilitation interventions in patients with AECOPD have been largely reviewed, 10, 11, [18] [19] [20] [21] thus a first search limited to literature reviews was conducted from May to June 2016 in PubMed, Web of Knowledge, Scopus, and CINAHL. The original papers included in these reviews were extracted and searched for the outcome measures.
The latest available literature review on this theme was dated from 2012 and thus, a second search using the same keywords and databases but limited to original studies published from 2010 to June 2016 was also performed to identify all outcome measures most recently used by physiotherapists. An interval of 2 years until the most recent review in the theme seemed appropriate, as studies indicate that time from submission to publication can go up to 2 years. 22 In both searches, the reference lists of the identified studies were scanned for other potential eligible studies. Additionally, a weekly update was conducted until July 2016. The full search strategy can be found in eAppendix 1 (available at: https://academic.oup.com/ptj). First, title and abstract were screened, and if the articles were considered relevant, full text was analyzed. Studies were included if they met the following 3 criteria: aimed to assess pulmonary rehabilitation or one of its components; assessed patients with an AECOPD within 3 weeks of the onset as this is the mean time needed for recovery 2, 23, 24 ; and were written in English, Spanish, French, or Portuguese. Studies were excluded if they were conducted in animals; patients requiring emergency intubation, intensive care unit management, and/or mechanical ventilation; patients with compromised neurological status or hemodynamic instability; patients performing self-management programs only; and patients assessed only after discharge for AECOPD. Book chapters, abstracts of communications or meetings, letters to the editor, commentaries to studies, unpublished work and study protocols were excluded. The quality of the outcome measures reported was determined using the rating system for measurement properties proposed by Terwee et al. 27 For each measurement property a criterion is defined for positive, negative and indeterminate rating.
Data synthesis and analysis. Data on PROMs and clinical outcome measures were separately analyzed. For each measurement property (ie, reliability, validity, responsiveness and interpretability), a synthesis of the quality of the study, using the COSMIN criteria, 26 and of the quality outcome measure, using the system of Terwee et al, 27 was performed.
The consistency of the quality assessment performed by the 2 reviewers was explored with an interrater agreement analysis using the Cohen kappa for each box of the COSMIN criteria. The Cohen kappa value ranges from 0 to 1 and can be categorized as slight (<0.2), fair (0.21-0.4), moderate (0.41-0.6), substantial (0.61-0.8), or almost perfect (>0.81) agreement. 28 
Results
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Study selection. A total of 220 literature reviews were found. After duplicates were removed (n = 66) and exclusions were made on the basis of abstract and title screenings (n = 22), 132 full texts were screened and 15 literature reviews that reported on pulmonary rehabilitation interventions in patients with AECOPD were included. Additionally, 24 original studies included in the 15 reviews were extracted and searched for outcome measures not reported in the reviews.
The search conducted for original studies published after 2010 retrieved 257 original studies. After duplicates were removed (n = 134) and exclusions were made on the basis of abstract and title screenings (n = 23), 100 full texts were screened and 13 original studies were included. Thus, a total of 37 original studies were searched for outcome measures. A flow diagram concerning the literature reviews and original studies search and reasons for studies exclusions can be found in the eFigure (available at: https://academic.oup.com/ptj).
Study characteristics. The 37 studies included were conducted in 19 different countries. A steady increase in the number of studies investigating pulmonary rehabilitation in patients with AECOPD was observed, with only 7 papers published from 1964 to 2000 and 37 by 2016. Most studies were randomized control trials (n = 31) 15, 16, conducted with inpatients (n = 27), 15, 16, 29, 30, 33, 35, [37] [38] [39] [40] [41] 43, [45] [46] [47] [48] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] followed by hospital outpatient departments (n = 6), 15, 37, 38, 42, 44, 49 inpatients plus patients' homes (n = 3), 31, 32, 50 community settings (n = 3), 34, 62, 63 and patients' homes (n = 1) 36 (Tabs. 1 and 2).
Outcomes and outcome measures.
Twenty-three PROMs and 18 clinical outcome measures were identified. The most common patient-reported outcomes assessed were dyspnea (n = 24), using the modified Borg Scale (mBorg) 30, 32, 38, 39, 42, 44, 46, [52] [53] [54] [55] 58, 62, 63 (n = 14), and health-related quality of life (n = 23), using the St George Respiratory Questionnaire (SGRQ) 16, [34] [35] [36] [37] 39, 42, 44, [49] [50] [51] 54, 56, 58, 59 (n = 15). The most common clinical outcomes assessed were functional exercise capacity (n = 24), using the 6-minute The methodological quality of each study and the quality of the measurement properties of each measure can be found in Tables 3 and 4 . The agreement between the 2 independent reviewers using the COSMIN quality assessment was substantial (κ = 0.688).
The characteristics of the included studies and synthesis of the results per outcome and outcome measure can be found in eAppendix 3 (available at: https://academic.oup.com/ptj; eTab. 1a and eTab. 1b).
Quality and properties of PROMs.
Reliability was studied for 67, 69 Studies were rated as poor mainly because an analysis of the unidimensionality of the scale was not preformed.
Measurement properties presented positive results in all reliability categories assessed (ie, internal consistency and test-retest; measurement error has not been assessed) and for all outcome measures (Tab. 3).
Validity was studied for most PROMs, except for the mBorg, visual analog scale, Short-Form 6D, and Nottingham Health Profile, in 21 studies. Overall, the methodological quality of the studies was rated from poor to fair, except for structural validity studied in the CRQ and the CAT, which were rated excellent. 64, 65 For criterion validity, reasons for rating "poor" were related with the inadequacy of the gold standard used as comparator. Regarding to construct validity, weaknesses included lack of formulation of hypotheses and lack of description of the comparator instrument. 66, [68] [69] [70] 72, 75, 76, 79, 80, 82 , negative in 2 studies (ie, SGRQ and CRQ) 64, 73 , and positive in 7 studies (ie, SGRQ, CRQ, CCQ, CAT, and Cough and Sputum Assessment Questionnaire) 65, 67, [74] [75] [76] 78, 84 (Tab. 3).
Responsiveness was studied for most PROMs, except for the modified MRC, MRC, extended MRC, Breathing Problems Questionnaire, GOLD + SSI, Manchester Respiratory Activities of Daily Living Questionnaire, and LCADL, in 19 studies of poor to fair methodological quality. 64, [66] [67] [68] [69] [72] [73] [74] [75] [76] [77] 79, 80, [84] [85] [86] [87] [88] [89] Common weaknesses of studies included lack of description of the comparator instrument and inadequacy of design and statistical methods used. Responsiveness was indeterminate in 14 studies (ie, SGRQ, CCQ, COPD severity score, EQ-5D, Short-Form 6D, Nottingham Health Profile, Measure Your Medical Outcome Profile, Medical Outcomes Study 6-Item General Health Survey, EXACT-PRO, Cough and Sputum Assessment Questionnaire, mBorg, visual analog scale, and CCQ), [66] [67] [68] [69] 73, 75, 77, 79, 80, [84] [85] [86] [87] 89 negative in 5 studies (ie, SGRQ, CRQ, CAT, and EQ-5D), 64, 72, 74, 75, 79 and positive in 3 studies (ie, BDI/TDI and CAT) 72, 76, 88 (Tab. 3).
Interpretability was found in 2 studies which presented values of the minimal clinically important difference (MCID) for the CRQ (MCID = 1.01) 64 and the CCQ (MCID = 0.44). 68 Quality and properties of clinical measures. Reliability was not studied for any of the clinical outcome measures found (Tab. 4).
Validity was studied for all clinical outcome measures in 8 studies of fair to poor methodological quality. 70, 72, [90] [91] [92] [93] [94] [95] For criterion validity, reasons for rating "poor" were related with the inadequacy of the gold standard used as comparator, whereas for construct validity reasons were related to the lack of formulation of hypotheses and the lack of description of the comparator instrument.
Overall, measurement properties presented positive results for criterion validity assessed in 4 studies (ie, peripheral oxygen saturation [SpO2], forced vital capacity, and computerized respiratory sounds) 70, 90, 93, 94 ; however, in 1 study assessing the FEV1, criterion validity was indeterminate. 70 Regarding to construct validity, indeterminate results were found in 2 studies (ie, SpO2, peak expiratory flow [PEF], FEV1, and forced vital capacity) 70, 92 and positive results in 3 studies (ie, SpO2, PEF, and time spent in weight-bearing activities assessed with an accelerometer) 90, 91, 95 (Tab. 4).
Responsiveness was studied for the PEF and FEV1 in 2 studies 72,91 of fair and poor methodological quality, respectively. The study was rated as poor because it did not describe the measurement properties of the comparator instrument.
Responsiveness was rated positive for the PEF 91 and indeterminate for the FEV1 72 (Tab. 4).
Interpretability was not studied for any of the clinical outcome measures found (Tab. 4).
Discussion
To our knowledge, this is the first systematic review to provide a comprehensive overview of the measurement properties of the outcome measures most used in pulmonary rehabilitation programs during AECOPD and that can be easily applied in a community setting. Twenty-three PROMs and 18 clinical outcome measures were identified in intervention studies. The most used measures were the St George Respiratory Questionnaire (n = 15/37) and the 6-minute walk test (n = 21/37). Several measures have been used only in isolated studies (ie, New York Heart Association Functional Classification, Activities of Daily Living Dyspnea Scale, diaries, Functional Assessment of Chronic Illness Therapy, a feeling thermometer [visual analog scale presented in the form of a thermometer with 100 marked intervals], 15 mBorg fatigue, LCADL, 3-minute step test, 3-minute walk test, 2-minute step-in-place test, FEV1/forced vital capacity, computerized respiratory sounds, fat-free mass index, body mass index, accelerometer, quadriceps twitch responses, and maximum inspiratory pressure). Measurement properties were only synthesized for 22 PROMs and 7 clinical outcome measures. The methodological quality of most studies was poor, and the results obtained for the measurement properties were indeterminate. The PROMs and clinical outcome measures exhibiting the most appropriate measurement properties were the CAT and SpO2, respectively.
The most used PROMs were the mBorg and the SGRQ. Dyspnea and health-related quality of life have been reported as the outcomes that better reflect the overall impact of the disease 96 and, therefore their monitoring during AECOPD, with appropriate outcome measures, is essential to guide health professionals on the most effective interventions. Nevertheless, the measurement properties of the mBorg have been little reported and, when reported, in studies of poor methodological quality. The BDI/TDI, although not commonly used, was the only outcome measure which rated fair and positive for responsiveness on dyspnea. The SGRQ has shown appropriate test retest reliability but inconclusive validity and responsiveness. Although, the SGRQ has strong measurement properties in stable patients with COPD, 24, 97 it reports to the past month, 3 months and 1 year. These inappropriate timeframes to assess improvements from an AECOPD, which usually takes 1 to 3 weeks to be meaningful to patients, 23, 98 might explain some of the divergent results found. Measurement properties of CAT have been assessed in a reasonable number of studies of fair methodological quality 65, 75, 76, 78, 88 and positive results have been found. Therefore, the BDI/ TDI and CAT may be promising PROMs to assess the effectiveness of community-based pulmonary rehabilitation in patients with AECOPD.
The most used clinical outcome measures were the FEV1 and the 6-minute walk test. However, the measurement properties of the FEV1 were found in studies of poor methodological quality and no studies were found reporting on the measurement properties of the 6-minute walk test in patients with AE-COPD which impaired conclusions regarding its use. Similarly to exercise tolerance, no studies were found reporting on measurement properties of muscle strength. Currently, it is known that the inflammatory effects of AECOPD are not confined to the lungs but also impair peripheral muscle strength and exercise tolerance. 1 Declines in these outcomes are independent predictors of hospitalizations and mortality. 99, 100 Early rehabilitation may play a crucial role in preventing and reducing losses in exercise capacity, muscle strength and musculoskeletal dysfunction, 16, 43 thus possibly reverting this cascade of events. Nevertheless, there is the urgent need to establish the measurement properties of clinical outcome measures for AECOPD to assess patients' dysfunctions, plan interventions, and verify their effectiveness. 95 Poor/+ Not free a BMI = body mass index; CRS = computerized respiratory sounds; FEV1 = forced expiratory volume in 1 s; FVC = forced vital capacity; PEF = peak expiratory flow; pp = percentage of predicted normal value; SpO2 = peripheral oxygen saturation; + = positive; − = negative; ? = indeterminate.
This systematic review evidenced that the conflicting results of pulmonary rehabilitation programs in patients with AECOPD 10,15,16,50 may not be related to the quality of treatment but with the lack of appropriateness of measurement proprieties of the outcome measures used. Additionally, whilst the methodology of this review target only measures that could be implemented in community settings (ie, simple and accessible measures), our results can also be applicable to other clinical settings where these measures are available. Nevertheless, since most AECOPD are recommended to be managed in the community and community-based pulmonary rehabilitation might be a promising intervention for minimizing a patient's decline and prevent recurrence, robust studies on the validity, reliability and responsiveness, as well as on availability, cost and interpretability (ie, by establishing the MCID), of outcome measures are urgently needed. These studies will contribute to clarify the role of community-based pulmonary rehabilitation in patients with AECOPD.
Study Limitations
This study has some limitations that need to be acknowledged. Several relevant studies for this systematic review [67] [68] [69] [71] [72] [73] 75, [77] [78] [79] [81] [82] [83] 85, 86, [88] [89] [90] [91] [92] [93] [94] [95] were not found with the validated search strategy used and were only included after searching through the reference lists of the reviewed studies. Relevant studies may have fallen out of the search due the absence of keywords related to measurement properties in their title, abstract or keywords, which impaired the filter used to identify them. Adequate use of the Medical Subject Headings (MESH) terms is warranted to identify the purpose of the studies and improve the quality of the results found in future systematic reviews.
This systematic review has followed the COSMIN recommendations to assess the quality of the included studies. The COSMIN was originally developed for health-related PROMs, such as questionnaires, 26 and thus its validity, reliability and adequacy for assessing the methodological quality of clinical studies and outcome measures, may be questioned. Nonetheless, in the absence of a measure specifically designed to evaluate such studies and outcome measures, the COSMIN is indicated as an adequate alternative tool. 101, 102 The selection of studies was performed by 1 reviewer which could have caused bias in the studies selection. This limitation has been mitigated by consulting a second reviewer when uncertainties were found and by defining strict inclusion and exclusion criteria prior to studies selection.
Finally, 3 of the studies included presented combined results of stable and exacerbated patients with COPD 69, 73, 74 which could have affected some of the conclusions established. Nevertheless, the results of these studies have been considered within the universe of all studies included, and thus we believe that any potential bias that could have been introduced was diluted. Future studies should focus on patients with AECOPD only, so that recommendations regarding its measurement properties can be established with confidence.
Conclusions
Although a large number of outcome measures easy to implement in a community-based setting have been used to assess pulmonary rehabilitation in patients with AECOPD, their measurement properties have been poorly studied. Given the wide availability of measures it does not seem necessary to develop new outcome measures to be used in community-based pulmonary rehabilitation of patients with AECOPD. Instead, studies following the COSMIN standards to evaluate the measurement properties (ie, reliability, validity and responsiveness) of the existing outcome measures are recommended. Such studies would contribute to clarify the role of community-based pulmonary rehabilitation in patients with AECOPD and guide the development of core outcome sets. 
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